Literature DB >> 32238717

PRC2 Components Maintain DNA Hypermethylation of the Upstream Promoter and Regulate Robo4 Expression in Endothelial Cells.

Kohei Izawa1, Keisuke Shirakura1, Koji Kakiuchi1, Nobuaki Funahashi1, Naoki Maekawa1, Nobumasa Hino1, Toru Tanaka1, Takefumi Doi1, Yoshiaki Okada1.   

Abstract

Roundabout4 (Robo4) is an endothelial cell-specific protein that stabilizes the vasculature in pathological angiogenesis and inflammation. We previously determined a 3-kb Robo4 promoter and demonstrated the importance of the upstream region for nuclear factor-kappaB (NF-κB)-mediated promoter activation induced by tumor necrosis factor α (TNFα). This region contains unique genomic features, including promoter region-specific DNA hypermethylation and chromatin condensation; however, the function of the region remains poorly understood. In this study, we analyzed the DNA sequences of the region and identified a motif for polycomb repressive complex 2 (PRC2). Chromatin immunoprecipitation assay indicates the binding of the PRC2 component, SUZ12, to the motif. A mutation in the motif decreased DNA methylation in embryonic stem cells and increased Robo4 promoter activity in endothelial cells. An inhibitor for the PRC2 component, EZH2, induced the promoter activity and expression of Robo4 in endothelial cells treated with or without TNFα. Taken together, these results indicate that the PRC2 components maintain DNA hypermethylation and suppress Robo4 expression via the PRC2 binding motif in the upstream promoter.

Entities:  

Keywords:  DNA methylation; Roundabout4; endothelial cell; gene regulation; polycomb repressive complex 2

Year:  2020        PMID: 32238717     DOI: 10.1248/bpb.b19-01014

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cells.

Authors:  Taito Kashio; Keisuke Shirakura; Mayumi Kinoshita; Maaya Morita; Ryosuke Ishiba; Kosuke Muraoka; Tomoaki Kanbara; Masato Tanaka; Risa Funatsu; Nobumasa Hino; Shohei Koyama; Ryo Suzuki; Yasuo Yoshioka; Taiki Aoshi; Takefumi Doi; Yoshiaki Okada
Journal:  Tissue Barriers       Date:  2021-05-06

2.  LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.

Authors:  Xianguang Yang; Susheng Miao; Xionghui Mao; Cheng Xiu; Ji Sun; Rong Pei; Shenshan Jia
Journal:  Pathol Oncol Res       Date:  2021-04-01       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.